Can Fite BioPharma Ltd (CANF)
AMEX
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -49.217 | -52.069 | -86.239 | -156.579 | -171.306 | -102.129 | -68.885 | -79.224 |
Return on Equity (%) | -95.31 | -135.358 | -224.41 | -462.708 | -355.989 | -148.661 | -107.913 | -142.492 |
Return on Invested Capital (%) | -119.835 | -214.808 | -216.77 | -528.593 | -371.883 | -125.557 | -107.097 | -152.963 |
Operating Margin (%) | -4109.202 | -543.495 | -160.733 | -600.295 | -1845.347 | -1478.429 | -1255.926 | -1027.456 |
Net Profit Margin (%) | -4069.325 | -588.181 | -172.016 | -621.309 | -1986.632 | -1782.532 | -1255.926 | -1027.456 |
Book Value Per Share | 0.529 | 0.319 | 0.075 | 0.02 | 0.013 | 0.018 | 0.005 | 0.005 |
Earnings Per Share | -0.942 | -0.519 | -0.163 | -0.105 | -0.033 | -0.019 | -0.012 | -0.006 |
Cash Per Share | 1.108 | 0.365 | 0.089 | 0.022 | 0.018 | 0.005 | 0.004 | 0.003 |
Working Capital Per Share | 1.038 | 0.529 | 0.118 | 0.032 | 0.018 | 0.021 | 0.008 | 0.006 |
Operating Profit Per Share | 0.023 | 0.144 | 0.095 | 0.017 | 0.002 | 0.001 | 0.001 | 0.001 |
EBIT Per Share | -0.955 | -0.517 | -0.163 | -0.105 | -0.031 | -0.015 | -0.012 | -0.006 |
EBITDA Per Share | -0.955 | -0.517 | -0.163 | -0.105 | -0.031 | -0.015 | -0.012 | -0.006 |
Free Cash Flow Per Share | -0.943 | -0.52 | -0.162 | -0.105 | -0.033 | -0.019 | -0.012 | -0.006 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Fin d'année 31 Décembre 2023 | Mar 2022 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 |
---|---|---|---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -1156.098 | N/A | N/A | N/A | -1301.02 | N/A | N/A | N/A |
Net Profit Margin (%) | -1187.317 | N/A | N/A | N/A | -1301.02 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 10,08M |
Ratio cours/bénéfice | 0 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 0 |
Rendement de dividende | - |
Actions en circulation | 5,57M |
Volume moyen (1 semaine) | 169,88k |
Volume moyen (1 mois) | 246,4k |
Variation sur 52 semaines | -12,62% |
Plus haut sur 52 semaines | 4,69 |
Plus bas sur 52 semaines | 1,29 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales